Physician profile
Harry T Temple
NPI 1992769517
$115,191.10
in general payments reported to CMS, 2019-2025
11 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $262 · 2021: $13K · 2022: $14K · 2023: $19K · 2024: $25K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $49K · Travel and Lodging: $8,423 · Food and Beverage: $2,988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,675.00 |
| Travel and Lodging | $8,422.50 |
| Food and Beverage | $2,988.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $96,772.66 | 2019-2025 | Gmrs, Mako, Aequalis |
| Paragon 28, INC. | $13,019.90 | 2019 | |
| Onkos Surgical, INC. | $4,115.40 | 2019-2025 | Eleos Limb Salvage System |
| Carbofix Orthopedics INC | $564.78 | 2023-2024 | |
| Illuminoss Medical, INC. | $284.44 | 2023-2024 | Photodynamic Bone Stabilization Procedure Pack |
| Sanara Medtech INC. | $187.28 | 2023 | Celleraterx |
| Uoc USA INC | $123.24 | 2025 | U2 |
| Daiichi Sankyo INC. | $82.73 | 2022 | |
| Si-Bone, INC. | $20.72 | 2022 | |
| Zimmer Biomet Holdings, INC. | $19.95 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$952,500.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Temple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.